FT 13299 has taken a significant step by filing an amendment to its registration statement, enabling it to offer its units to the public. This move is crucial as it marks the company's entry into the biotechnology investment space, seeking to attract investors looking for capital appreciation.

In the filing dated October 30, 2026, FT 13299, a unit investment trust, aims to leverage the growing biotechnology sector by investing in a diversified portfolio of common stocks from biotechnology and pharmaceutical companies. This strategic focus reflects the increasing interest in biotechnology as a lucrative investment avenue.

Background

FT 13299 is a series of a unit investment trust known as the FT Series. It operates under the jurisdiction of the Securities and Exchange Commission (SEC) and is registered under the Securities Act of 1933. The company is incorporated in Illinois, and its principal office is located in Wheaton, Illinois. The trust is sponsored by First Trust Portfolios L.P., which is known for managing various investment portfolios.

The recent filing is part of a series of submissions by FT 13299, including a previous filing on August 25, 2026, which was an S-6 form. The current amendment reflects the company's ongoing efforts to enhance its investment offerings and attract potential investors.

What the Filing Says

The filing states that FT 13299 is registering an indefinite number of units under Rule 24f-2, which allows unit investment trusts to register units for public sale. The amendment specifies that the proposed sale to the public will occur as soon as practicable after the effective date of the registration statement. The filing indicates that it is intended to become effective on October 30, 2026, at 2:00 p.m.

Impact

This filing may significantly impact potential investors looking for opportunities in the biotechnology sector. By offering units in a trust focused on biotechnology, FT 13299 aims to attract investors interested in capital appreciation through a diversified portfolio. Additionally, this move could influence competitors in the unit investment trust market, as they may need to adapt their offerings to remain competitive.

What's Next

The filing does not specify what happens next, but it indicates that the company is preparing for the public offering of its units. Investors and market participants will be watching closely for further developments regarding the offering and the performance of the trust.